Arrowhead Pharmaceuticals, Inc. Earnings

Arrowhead Pharmaceuticals, Inc.’s revenue jumped 10461.32% since last year same period to $264.03Mn in the Q4 2025. On a quarterly growth basis, Arrowhead Pharmaceuticals, Inc. has generated 2.95% jump in its revenue since last 3-months.

Arrowhead Pharmaceuticals, Inc.’s net profit jumped 117.8% since last year same period to $30.81Mn in the Q4 2025. On a quarterly growth basis, Arrowhead Pharmaceuticals, Inc. has generated 229.73% jump in its net profits since last 3-months.

Arrowhead Pharmaceuticals, Inc.’s net profit margin jumped 100.17% since last year same period to 11.67% in the Q4 2025. On a quarterly growth basis, Arrowhead Pharmaceuticals, Inc. has generated 226.02% jump in its net profit margins since last 3-months.

Arrowhead Pharmaceuticals, Inc.’s earning per share (EPS) estimates for the current quarter stand at 0.11 - a 137.08% jump from last quarter’s estimates.

Arrowhead Pharmaceuticals, Inc.’s earning per share (EPS) estimates for the current year stand at 0.11.

Arrowhead Pharmaceuticals, Inc.’s earning per share (EPS) jumped 115.83% since last year same period to 0.22 in the Q4 2025. This indicates that the Arrowhead Pharmaceuticals, Inc. has generated 115.83% annual rate of jump in its earning per share (EPS) in the last 4 quarters.